SEC Form D · filed November 20, 2023
Cantai Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (12)
Joshua Brandt · Philadelphia, PAExecJames P. Scopa · South San Francisco, CAExec · DirectorGeeta Vemuri · Philadelphia, PAExec · DirectorJoshua Brandt · Philadelphia, PAExecGeeta Vemuri · Philadelphia, PAExec · DirectorDavid Swartz · Calabasas, CAExecCarole P. Nuechterlein · South San Francisco, CAExec · DirectorMatthew Armendariz · Calabasas, CAExecErrik Anderson · Philadelphia, PAExec · DirectorErrik Anderson · Philadelphia, PAExec · DirectorRoss Leimberg · Philadelphia, PAExecRoss Leimberg · Philadelphia, PAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗